Christopher Nelson
Acute Care · Aberdeen, SDNPI 1720376825
Payments from drug & device makers
Across 550 payments — averaging $561.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$66K
- Amgen$49K
- Rigel Pharmaceuticals, Inc.$39K
- Beigene USA, Inc.$37K
- E.r. Squibb & Sons, L.L.C.$33K
- Johnson & Johnson$28K
- plus $57K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 124 | $66,237 |
| Amgen | 77 | $49,194 |
| Rigel Pharmaceuticals, Inc. | 56 | $38,796 |
| Beigene USA, Inc. | 50 | $37,239 |
| E.r. Squibb & Sons, L.L.C. | 55 | $32,535 |
| Johnson & Johnson | 41 | $28,413 |
| AstraZeneca(2 entities) | 28 | $17,863 |
| AbbVie | 25 | $10,410 |
| Bristol Myers Squibb | 18 | $8,150 |
| Gilead | 14 | $7,255 |
| Hologic Sales And Service, LLC | 1 | $4,410 |
| Epizyme, Inc. | 6 | $3,264 |
| Merck | 12 | $3,224 |
| Sanofi | 3 | $676 |
| Daiichi Sankyo Inc. | 2 | $200 |
| TG Therapeutics, Inc. | 1 | $185 |
| Astellas Pharma US Inc | 4 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $117 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Pfizer | 5 | $95 |
| Novartis | 5 | $90 |
| Caris MPI, Inc. | 1 | $58 |
| AVEO Pharmaceuticals, Inc. | 3 | $55 |
| Eisai Inc. | 3 | $53 |
| Iovance Biotherapeutics, Inc. | 2 | $47 |
| Myriad Genetic Laboratories, Inc. | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Seagen Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $16 |
| Array Biopharma Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
How this compares
Too few acute care providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Aberdeen
- Wylie BarnesAberdeen$566
- Paulette NankivelRapid City$5K
- Jessica TvedtRapid City$3K
- Mikayla CrockerRapid City$3K
- Kali HuiskesSioux Falls$2K
- Ashley HeupelSioux Falls$1K
- Lonny HeinemannSioux Falls$187
- Katelyn BauerSioux Falls$164
- Jamie van LentSioux Falls$160
- Wade SendelbachSioux Falls$156
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.